Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration.

Lauper K, Iudici M, Mongin D, Bergstra SA, Choquette D, Codreanu C, Cordtz R, De Cock D, Dreyer L, Elkayam O, Hauge EM, Huschek D, Hyrich KL, Iannone F, Inanc N, Kearsley-Fleet L, Kristianslund EK, Kvien TK, Leeb BF, Lukina G, Nordström DC, Pavelka K, Pombo-Suarez M, Rotar Z, Santos MJ, Strangfeld A, Verschueren P, Courvoisier DS, Finckh A

Open source

DOI: 10.1136/annrheumdis-2022-222586
Published: 2022 Oct
Container: Annals of the rheumatic diseases
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/annrheumdis-2022-222586,
  title = {Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration.},
  author = {Lauper K and Iudici M and Mongin D and Bergstra SA and Choquette D and Codreanu C and Cordtz R and De Cock D and Dreyer L and Elkayam O and Hauge EM and Huschek D and Hyrich KL and Iannone F and Inanc N and Kearsley-Fleet L and Kristianslund EK and Kvien TK and Leeb BF and Lukina G and Nordström DC and Pavelka K and Pombo-Suarez M and Rotar Z and Santos MJ and Strangfeld A and Verschueren P and Courvoisier DS and Finckh A},
  year = {2022},
  journal = {Annals of the rheumatic diseases},
  doi = {10.1136/annrheumdis-2022-222586},
  url = {https://doi.org/10.1136/annrheumdis-2022-222586}
}

RIS

TY  - JOUR
TI  - Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration.
AU  - Lauper K
AU  - Iudici M
AU  - Mongin D
AU  - Bergstra SA
AU  - Choquette D
AU  - Codreanu C
AU  - Cordtz R
AU  - De Cock D
AU  - Dreyer L
AU  - Elkayam O
AU  - Hauge EM
AU  - Huschek D
AU  - Hyrich KL
AU  - Iannone F
AU  - Inanc N
AU  - Kearsley-Fleet L
AU  - Kristianslund EK
AU  - Kvien TK
AU  - Leeb BF
AU  - Lukina G
AU  - Nordström DC
AU  - Pavelka K
AU  - Pombo-Suarez M
AU  - Rotar Z
AU  - Santos MJ
AU  - Strangfeld A
AU  - Verschueren P
AU  - Courvoisier DS
AU  - Finckh A
PY  - 2022
JO  - Annals of the rheumatic diseases
DO  - 10.1136/annrheumdis-2022-222586
UR  - https://doi.org/10.1136/annrheumdis-2022-222586
ER  -

APA

K, L., M, I., D, M., SA, B., D, C., C, C., R, C., D, D. C., L, D., O, E., EM, H., D, H., KL, H., F, I., N, I., L, K., EK, K., TK, K., BF, L., G, L., DC, N., K, P., M, P., Z, R., MJ, S., A, S., P, V., DS, C., & A, F. (2022). Effectiveness of TNF-inhibitors, abatacept, IL6-inhibitors and JAK-inhibitors in 31 846 patients with rheumatoid arthritis in 19 registers from the 'JAK-pot' collaboration.. Annals of the rheumatic diseases. https://doi.org/10.1136/annrheumdis-2022-222586

Source records

pubmed · retrieved 2026-11-11T01:43:22.807Z